SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 77 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $19,000 | -5.0% | 72,202 | -13.4% | 0.00% | – |
| Q1 2016 | $20,000 | -69.7% | 83,359 | -55.5% | 0.00% | -100.0% |
| Q4 2015 | $66,000 | -84.2% | 187,400 | -21.8% | 0.00% | -83.3% |
| Q3 2015 | $417,000 | -23.1% | 239,700 | -1.3% | 0.01% | -25.0% |
| Q2 2015 | $542,000 | +138.8% | 242,961 | +107.8% | 0.01% | +100.0% |
| Q1 2015 | $227,000 | +99.1% | 116,935 | +172.5% | 0.00% | +100.0% |
| Q4 2014 | $114,000 | -57.5% | 42,919 | -51.8% | 0.00% | -50.0% |
| Q3 2014 | $268,000 | +77.5% | 89,061 | +154.4% | 0.00% | +33.3% |
| Q1 2014 | $151,000 | -74.6% | 35,006 | -69.2% | 0.00% | -66.7% |
| Q4 2013 | $595,000 | +1252.3% | 113,618 | +1189.2% | 0.01% | +800.0% |
| Q2 2013 | $44,000 | – | 8,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,061,186 | $82,646,000 | 87.47% |
| Geller Advisors LLC | 187,323 | $418,000 | 0.24% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 430,749 | $961,000 | 0.22% |
| Verity Asset Management, Inc. | 81,694 | $182,000 | 0.16% |
| CAXTON CORP | 52,000 | $116,000 | 0.12% |
| Catalyst Capital Advisors LLC | 400,000 | $892,000 | 0.10% |
| Cutler Capital Management, LLC | 72,500 | $161,000 | 0.07% |
| STONERIDGE INVESTMENT PARTNERS LLC | 239,202 | $533,000 | 0.07% |
| SECOR Capital Advisors, LP | 35,087 | $78,000 | 0.03% |
| Roundview Capital LLC | 29,100 | $65,000 | 0.02% |